陈歆, 程艾邦, 许建忠, 李燕, 王继光 . 中国高血压患者原发性醛固酮增多症的前瞻性筛查研究进展[J]. 诊断学理论与实践, 2020 , 19(05) : 450 -453 . DOI: 10.16150/j.1671-2870.2020.05.002
| [1] | Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen?[J]. Eur Heart J. 2014 May 14; 35(19):1245-1254. |
| [2] | Hundemer GL, Vaidya A. Primary aldosteronism diagnosis and management: a clinical approach[J]. Endocrinol Metab Clin North Am, 2019, 48(4):681-700. |
| [3] | Käyser SC, Dekkers T, Groenewoud HJ, et al. Study hete-rogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis[J]. J Clin Endocrinol Metab, 2016, 101(7):2826-2835. |
| [4] | Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice[J]. J Am Coll Cardiol, 2017, 69(14):1811-1820. |
| [5] | Umpierrez GE, Cantey P, Smiley D, et al. Primary aldosteronism in diabetic subjects with resistant hypertension[J]. Diabetes Care, 2007, 30(7):1699-1703. |
| [6] | Prejbisz A, Florczak E, Klisiewicz A, et al. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension[J]. Endokrynol Pol, 2013, 64(5):363-367. |
| [7] | Calhoun DA, Nishizaka MK, Zaman MA, et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea[J]. Chest, 2004, 125(1):112-117. |
| [8] | Di Murro A, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism[J]. J Renin Angiotensin Aldosterone Syst, 2010, 11(3):165-172. |
| [9] | Li M, Ge Q, Sheng CS, et al. Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apnea-hypopnea syndrome[J]. J Hum Hypertens, 2019, 33(9):693-700. |
| [10] | Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis[J]. Lancet Diabetes Endocrinol, 2018, 6(1):41-50. |
| [11] | Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol, 2005, 45(8):1243-1248. |
| [12] | Rossi GP, Maiolino G, Flego A, et al. Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term[J]. Hypertension, 2018, 71(4):585-591. |
| [13] | Rossi GP, Cesari M, Cuspidi C, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism[J]. Hypertension, 2013, 62(1):62-69. |
| [14] | Zhu L, Zhang Y, Zhang H, et al. Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy[J]. Medicine (Baltimore), 2016, 95(39):e4986. |
| [15] | Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrino-logy Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors[J]. Eur J Endocrinol, 2016, 175(2):G1-G34. |
| [16] | 中华医学会内分泌学分会肾上腺学组. 原发性醛固酮增多症诊断治疗的专家共识[J]. 中华内分泌代谢杂志, 2020, 36(9):727-736. |
| [17] | Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Hypertension, 2018, 71(6):e13-e115. |
| [18] | 冷敏, 刘爱云, 司家峰, 等. 化学发光法检测鲁西健康人群肾素-血管紧张素-醛固酮系统参考范围及影响因素[J]. 国际检验医学杂志, 2018, 39(15):1910-1914. |
| [19] | Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2016, 101(5):1889-1916. |
/
| 〈 |
|
〉 |
